Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) EPS (Basic) (2018 - 2025)

TransMedics (TMDX) has 8 years of EPS (Basic) data on record, last reported at $3.1 in Q4 2025.

  • For Q4 2025, EPS (Basic) rose 1450.0% year-over-year to $3.1; the TTM value through Dec 2025 reached $5.6, up 423.36%, while the annual FY2025 figure was $5.6, 423.36% up from the prior year.
  • EPS (Basic) reached $3.1 in Q4 2025 per TMDX's latest filing, up from $0.71 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $3.1 in Q4 2025 and bottomed at -$0.78 in Q3 2023.
  • Average EPS (Basic) over 5 years is $0.15, with a median of -$0.06 recorded in 2023.
  • Peak YoY movement for EPS (Basic): tumbled 212.0% in 2023, then surged 1450.0% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$0.45 in 2021, then soared by 55.56% to -$0.2 in 2022, then surged by 160.0% to $0.12 in 2023, then surged by 66.67% to $0.2 in 2024, then soared by 1450.0% to $3.1 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were $3.1 in Q4 2025, $0.71 in Q3 2025, and $1.03 in Q2 2025.